BioX2: Biological Exploration Payload 2
MIT Space Exploration Initiative and Georgia Institute of Technology
Dr. Christopher E. Carr
BioX2 (Biological Exploration Payload 2) is targeted for launch to the International Space Station (ISS) in October 2022 to be a technological demonstration for biological sample automation, nucleic acid extraction, and nanopore sequencing in space. A stretch goal is to perform end-to-end operations on orbit and measure Darwinian evolution of Bacillus subtilis, which will help advance future space life detection missions.